The Gross Margin of Abattis Bioceuticals Corp (ATT.CN) is 67.62%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2019-09-30 | 67.62% |
| 2018-09-30 | 77.42% |
| 2017-09-30 | 68.11% |
| 2016-09-30 | - |